{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01959165: Phase 2 Interventional Completed Ulcerative Colitis
(2013)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00264706: Phase 1/Phase 2 Interventional Terminated Saphenous Vein Graft Disease
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04541589: Phase 2 Interventional Completed Sjogren's Syndrome
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04666649: Phase 1 Interventional Active, not recruiting Relapsed or Refractory Acute Myeloid Leukemia
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03414658: Phase 2 Interventional Active, not recruiting Breast Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01909245: Phase 2 Interventional Active, not recruiting Type 1 Diabetes Mellitus
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01507168: Phase 2 Interventional Completed Carcinoma, Hepatocellular
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04050462: Phase 2 Interventional Active, not recruiting Hepatocellular Carcinoma
(2019)
Source URL:
Class:
PROTEIN
